Rugo HS - Search Results

1

Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.

Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP. Chien AJ, et al. Among authors: rugo hs. Breast Cancer Res Treat. 2017 Aug;165(1):151-159. doi: 10.1007/s10549-017-4288-3. Epub 2017 May 13. Breast Cancer Res Treat. 2017. PMID: 28503722 Clinical Trial.

2

The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.

Rugo HS, Ahles T. Rugo HS, et al. Semin Oncol. 2003 Dec;30(6):749-62. doi: 10.1053/j.seminoncol.2003.09.008. Semin Oncol. 2003. PMID: 14663776 Review.

3

Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.

Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES. Lang JE, et al. Among authors: rugo hs. J Am Coll Surg. 2004 Dec;199(6):856-62. doi: 10.1016/j.jamcollsurg.2004.08.023. J Am Coll Surg. 2004. PMID: 15555967

4

Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.

Melisko ME, Hassin F, Metzroth L, Moore DH, Brown B, Patel K, Rugo HS, Tripathy D. Melisko ME, et al. Among authors: rugo hs. Clin Breast Cancer. 2005 Apr;6(1):45-54. doi: 10.3816/CBC.2005.n.008. Clin Breast Cancer. 2005. PMID: 15899072

5

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. Partridge SC, et al. Among authors: rugo hs. AJR Am J Roentgenol. 2005 Jun;184(6):1774-81. doi: 10.2214/ajr.184.6.01841774. AJR Am J Roentgenol. 2005. PMID: 15908529

6

The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.

Lin A, Rugo HS. Lin A, et al. Among authors: rugo hs. Curr Treat Options Oncol. 2007 Feb;8(1):47-60. doi: 10.1007/s11864-007-0008-2. Curr Treat Options Oncol. 2007. PMID: 17660958 Review.

7

Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy.

Rugo HS. Rugo HS. Clin Breast Cancer. 2007 Jul;7 Suppl 1:S21-8. doi: 10.3816/cbc.2007.s.003. Clin Breast Cancer. 2007. PMID: 17683650 Review.

8

The importance of distant metastases in hormone-sensitive breast cancer.

Rugo HS. Rugo HS. Breast. 2008 Jan;17 Suppl 1:S3-8. doi: 10.1016/S0960-9776(08)70002-X. Breast. 2008. PMID: 18279764 Review.

9

Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.

Melisko ME, Moore DH, Sneed PK, De Franco J, Rugo HS. Melisko ME, et al. Among authors: rugo hs. J Neurooncol. 2008 Jul;88(3):359-65. doi: 10.1007/s11060-008-9578-5. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398574

10

Risk communication with patients with breast cancer: cautionary notes about printing Adjuvant! estimates.

Belkora J, Rugo HS, Moore DH, Hutton D, Esserman L. Belkora J, et al. Among authors: rugo hs. Lancet Oncol. 2008 Jul;9(7):602-3. doi: 10.1016/S1470-2045(08)70158-X. Lancet Oncol. 2008. PMID: 18598923 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters